×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Agennix Stops Phase II/III Talactoferrin Study in Sepsis Due to Higher Death Rates
Genetic Engineering and Biotechnology News
Agennix has stopped its Phase II/III Oasis study evaluating lead candidate oral talactoferrin in the treatment of severe sepsis, after a data...
147 months ago
Lactoferrin and Lactoperoxidase Market 2023-2030 Insight View wi - SOUTHEAST
SOUTHEAST - NEWS CHANNEL NEBRASKA
This section of the Keyword market report containing 96 pages identifies various key manufacturers (Agennix, Fonterra Co-Operative Group, Milei,...
1 week ago
People in the News
Inquirer.com
Onconova Therapeutics Inc., a Newtown, Pa., and Pennington, N.J., cancer-drug developer, hired Thomas J. McKearn as president, research and...
137 months ago